Displaying results 1 - 12 of 15
COVID-19 and the liver
EASL Policy Statement on the Use of COVID-19 Vaccines in People with Chronic Liver Disease, Hepatobiliary Cancer, and Liver Transplant Recipients

EASL Policy Statement on the Use of COVID-19 Vaccines in People with Chronic Liver Disease, Hepatobiliary Cancer, and Liver Tr...

PDF
View
Liver Tumours
EASL Studio S1 E1: Liver Cancer Awareness Month

EASL Studio S1 E1: Liver Cancer Awareness Month

EASL Studio
View
Metabolism, Alcohol & Toxicity

Introduction and presentation of the NAFLD patient guideline

Webcasts
View
Metabolism, Alcohol & Toxicity

The user perspective

Webcasts
View
Metabolism, Alcohol & Toxicity

Changing the models of care

Webcasts
View
Metabolism, Alcohol & Toxicity

A practical example from the guideline

Webcasts
View
Metabolism, Alcohol & Toxicity

A multidisciplinary patient-centred approach

Webcasts
View
Metabolism, Alcohol & Toxicity
Non-alcoholic fatty liver disease: A patient guideline

Non-alcoholic fatty liver disease: A patient guideline

PDF
View
Liver Tumours
Liver Cancer Explained

Liver Cancer Explained

Infographics
View
General Hepatology
Public health

Public health

Best of EASL Congress
View
General Hepatology
ILC 2021 Takeaways – Public health

ILC 2021 Takeaways – Public health

Takeaways
View
COVID-19 and the liver
Ask EASL: podcast on COVID-19 vaccination in patients with liver disease

Ask EASL: podcast on COVID-19 vaccination in patients with liver disease

Podcasts
View
Displaying results 1 - 12 of 15